$2.48 - INAB | IN8bio, Inc. Common Stock

IN8bio, Inc. Common Stock (INAB)

IN8bio, Inc. Common Stock

XNAS:INAB

2.48

6.44%

Ask

$2.62 - 38.00

Bid

$2.33 - 65.00

Low

$2.31

High

$2.52

Open

$2.36

Prev Close

$2.33

52W High

12.53

52W Low

1.17

Volume

30937

Avg Vol (3m)

132549.4

Float

3214925.55

Chart

TendieTensor AI Analysis

Company

Asset Type: Common Stock

SIC Code: 2836

Sector: Health Technology

Industry: Biotechnology

Date Listed: 07/30/2021

Primary Exchange: XNAS

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

Phone: (646) 600-6438

Address: Empire State Building

Address 2: 350 5th Avenue, Suite 5330

City: New York

State: NY

Postal Code: 10118

Website

TendieTensor AI Analyst Recommendation: —

Fundamentals

Total Employees:

P/E (TTM)

-0.370000

P/B (TTM)

0.810739

Round Lot

100

Composit FIGI

BBG00XX9K1M2

Share Class FIGI

BBG00XX9K2G7

Share Class Shares Outstanding

4.54M

Weighted Shares Outstanding

4.54M

Technicals

RSI (14)

MACD Line

MACD Signal

SMA 20

SMA 50

EMA 50

Trend

Short Interest

—

Days to Cover

— —

Higher = harder to cover

Short Interest Δ

—

Prev: —

Short Volume Ratio (Today)

— —

5D avg: —

Squeeze Score (0–100)

—

Discussion